← Eichor
Study identifier: NCT07684924 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Early Ga-68 FAPI PET/MR After Acute Myocardial Infarction

Condition: Acute Myocardial Infarction (AMI)  ·  Sponsor: Ankara University

PhaseN/A
Planned participants25
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

Acute myocardial infarction (AMI) initiates a complex myocardial repair process involving inflammation, fibroblast activation, and extracellular matrix remodeling, which may ultimately lead to adverse left ventricular remodeling and impaired cardiac function. Fibroblast activation protein (FAP)-targeted positron emission tomography (PET) enables noninvasive visualization of activated fibroblasts and may provide an early imaging biomarker of myocardial remodeling. This prospective single-center observational study aims to evaluate myocardial fibroblast activation using Ga-68 FAPI PET/MR performed approximately 10 ± 2 days after AMI and to investigate its association with subsequent left ventricular remodeling. Serial cardiac magnetic resonance (CMR) examinations will be performed at 3 and 6 months to assess changes in ventricular function and remodeling. The study will investigate whether early myocardial FAPI uptake is associated with subsequent structural and functional changes detected by CMR and evaluate the potential role of Ga-68 FAPI PET/MR as an imaging biomarker for post-infarction remodeling.

This description comes directly from the study's public registry record.

Talk to the study team

Elgin Ozkan, Prof.Dr.  ·  +90 312 595 6445  ·  ozkanelgin@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Ankara University Faculty of Medicine, Department of Nuclear MedicineAnkara, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07684924